An old drug saves lives of COVID-19 patients

McMaster researcher Edward Mills and his team treated 739 randomly selected Brazilian COVID-19 patients with fluvoxamine, with another 733 receiving a placebo, between Jan. 15 to Aug. 6 of this year.

Every patient who received fluvoxamine during the trial was tracked for 28 days to determine their health outcomes and if they still need hospital treatment. Researchers found about a 30 per cent reduction in hospitalizations among those receiving fluvoxamine compared to those receiving the placebo.

Study: Death Rate from Parkinson’s Rising in U.S.

A new study shows that in the last two decades the death rate from Parkinson’s disease has risen about 63% in the United States. The research is published in the October 27, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that the death rate was twice as high in men as in women, and there was a higher death rate in white people than other racial/ethnic groups.

Burning and Tingling in Your Feet? You May Have Small Fiber Neuropathy

The number of people experiencing numbness, tingling and pain in their feet with no known cause has been increasing over the last two decades, according at a new study published in the October 27, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. Called small fiber neuropathy, the condition has different symptoms than large fiber neuropathy, which can cause weakness and balance issues. But in many cases people have both types of neuropathy.

Rutgers-Eagleton Resources and Expert Analysis for the 2021 Election

Experts at the Eagleton Institute of Politics at Rutgers University-New Brunswick can provide commentary and analysis about the upcoming 2021 election. Please contact Gabriella Morrone at [email protected] to get in touch with our experts. Additionally, the Institute provides public online…

Albert Einstein Cancer Center Researcher Receives NCI Outstanding Investigator Award to Study Two Deadly Blood Diseases

Ulrich G. Steidl, M.D., Ph.D., co-director of the Blood Cancer Institute and associate director of basic science at the Albert Einstein Cancer Center (AECC), has received a prestigious Outstanding Investigator Award from the National Cancer Institute (NCI).

Hereditary Disease Foundation Announces 2021 Prizes Recognizing Leadership in Huntington’s Disease Research

The Hereditary Disease Foundation today announced the recipients of its 2021 Awards: Elena Cattaneo, Director of the Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases at the University of Milan, will receive the Hereditary Disease Foundation Leslie Gehry Brenner Prize for Innovation in Science. Sarah Hernandez, postdoctoral fellow and project scientist in the Thompson Lab at University of California, Irvine, will receive the Nancy S. Wexler Young Investigator Prize.

Expert panel explores challenges, presents solutions to improve breast cancer outcomes for Black women

Although awareness and research activity is growing, much work still needs to be done to ensure equity in the diagnosis and treatment of breast cancer in Black women, according to an expert panel who spoke earlier this week at the virtual American College of Surgeons (ACS) Clinical Congress 2021.

ASTRO: Identifying unique genetic variants to overcome cancer treatment barriers

Dr. Robert Chin, a radiation oncologist with UCLA Jonsson Comprehensive Cancer Center, will describe recent research on personalized treatment for HPV-associated oropharyngeal cancer – particularly for patients with an inherited variant KRAS gene – during a panel discussion on radiation and cancer biology at ASTRO, the annual meeting of the American Society for Radiation Oncology.

UA Little Rock Postdoctoral Researcher Receives $40K Grant to Create Predictive Modeling of Refugee Numbers

The Arkansas Economic Development Commission, using flow-through funding from the National Science Foundation, has awarded a postdoctoral research fellow at UA Little Rock a grant worth more than $40,000 to create a machine learning model to predict refugee counts in the United States.

Scientists Spot Rare Neutrino Signal for Big Physics Finding

Scientists at Brookhaven National Laboratory developed a software toolkit that reconstructs and isolates neutrino data in 3D. This software directly enabled the long-awaited findings from the MicroBooNE experiment released today by Fermilab in four complementary analyses. The Wire-Cell team at Brookhaven Lab led one of the four analyses—the most sensitive analysis of the electron-neutrino interaction. Some components of the Wire-Cell toolkit were also used in the other three analyses.

New study reveals heart patients “orphaned” following aortic dissection repair despite ongoing risk of complications and death

A new study from the Peter Munk Cardiac Centre reveals that patients who survive an aortic dissection often fail to receive comprehensive post-surgical follow-up care leaving them vulnerable to a lifetime of sustained risk.

MicroBooNE experiment’s first results show no hint of a sterile neutrino

For more than a decade, scientists have wondered whether a theorized new particle, a fourth kind of neutrino called the sterile neutrino, might exist in our universe. Evidence of this would add a new particle to the physicists’ best theory, the Standard Model of Particle Physics. A new particle would be a radical shift in our understanding of the basic building blocks of the universe. MicroBooNE’s four new experimental results all show the same thing: no sign of the sterile neutrino. Instead, the results align with the Standard Model of Particle Physics. With sterile neutrinos further disfavored as the explanation for anomalies spotted in neutrino data, scientists are investigating other possibilities. Unexplained data point toward promising research areas and lead us to more fundamental truths about how physics works at the smallest level.

‘KSA’ metrics will improve military surgeons’ readiness

As the intensity of fighting in current conflicts has declined over the last several years, military surgeons have been challenged to maintain their skills for treating combat casualties. In response, the Knowledge, Skills and Abilities (KSA) Clinical Readiness Program was developed by the Uniformed Services University (USU) in collaboration with the American College of Surgeons (ACS) to measure clinical readiness and ensure quality care throughout the Military Health System (MHS). A new study, published in JAMA Surgery, used the KSA program to explore trends, and its findings could help inform changes to patient workflow to increase surgical workloads and ultimately enhance readiness.

All About Eve

New AI model called EVE, developed by scientists at Harvard Medical School and Oxford University, outperforms other AI methods in determining whether a gene variant is benign or disease-causing.
When applied to more than 36 million variants across 3,219 disease-associated proteins and genes, EVE indicated more than 256,000 human gene variants of unknown significance that should be reclassified as benign or pathogenic.

More than 75% of Texans have COVID-19 antibodies, one of the world’s largest assessments finds

A year after launching one of the world’s largest COVID-19 antibody surveys, Texas CARES, public health experts at The University of Texas Health Science Center at Houston (UTHealth Houston) and the Texas Department of State Health Services (DSHS) are estimating that over 75% of Texans have COVID-19 antibodies.

ASTRO: International meta-analysis quantifies impact of three prostate cancer therapy intensification strategies

An individual patient data (IPD) meta-analysis of randomized, controlled clinical trials provides strong evidence for the addition of androgen deprivation therapy (ADT) to definitive radiotherapy (RT) for the treatment of prostate cancer, with the projection that adding ADT to the treatment of 10-15 men would prevent the development of distant metastasis in one man.

FFAR Funding Supports Research to Speed Development of Perennial Crops

The Foundation for Food & Agriculture Research (FFAR) is providing a Seeding Solutions grant to the Donald Danforth Plant Science Center to accelerate development of perennial crops.